Joseph N Contessa Selected Research

Joseph N Contessa Research Topics

Disease

25	Neoplasms (Cancer) 01/2023 - 08/2003
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2013
6	Carcinoma (Carcinomatosis) 11/2023 - 06/2002
6	Glioma (Gliomas) 01/2014 - 08/2003
5	Squamous Cell Carcinoma of Head and Neck 09/2022 - 06/2013
5	Brain Neoplasms (Brain Tumor) 01/2019 - 09/2015
3	Neoplasm Metastasis (Metastasis) 07/2022 - 10/2013
3	Breast Neoplasms (Breast Cancer) 02/2008 - 01/2006
2	Bites and Stings (Sting) 09/2022 - 01/2021
2	Infections 01/2019 - 12/2017
2	Lung Neoplasms (Lung Cancer) 01/2018 - 09/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2018 - 08/2017
2	Melanoma (Melanoma, Malignant) 01/2016 - 01/2006
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Obesity 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Human Influenza (Influenza) 01/2022
1	Necrosis 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Flavivirus Infections 12/2017
1	Laryngeal Neoplasms (Laryngeal Cancer) 06/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2011
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2009
1	Adenocarcinoma 05/2008

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2003
9	Phosphotransferases (Kinase)IBA 01/2021 - 01/2006
5	Glycoproteins (Glycoprotein)IBA 01/2021 - 01/2014
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2016
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 12/2013
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2008
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2016 - 05/2008
3	tyrosine receptor (receptor, tyrosine)IBA 06/2013 - 02/2008
2	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 01/2021
2	InterferonsIBA 09/2022 - 01/2021
2	dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA 01/2018 - 12/2016
2	LuciferasesIBA 06/2013 - 10/2011
1	Lapatinib (GW572016)FDA Link 11/2023
1	Cisplatin (Platino)FDA LinkGeneric 11/2023
1	VaccinesIBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	Granzymes (Granzyme)IBA 10/2021
1	B7-H1 AntigenIBA 10/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	matrigelIBA 11/2019
1	Cetuximab (Erbitux)FDA Link 11/2019
1	AntibodiesIBA 11/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2019
1	NeuregulinsIBA 11/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	MagnesiumIBA 01/2019
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 12/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2016
1	Mannose (D-Mannose)IBA 01/2014
1	EnzymesIBA 01/2014
1	IsomerasesIBA 01/2014
1	Phosphates (Orthophosphate)IBA 01/2014
1	Cell Surface ReceptorsIBA 01/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2013
1	aclacinomycinsIBA 06/2013
1	TunicamycinIBA 06/2010
1	Polysaccharides (Glycans)IBA 06/2010
1	Monoclonal AntibodiesIBA 02/2008
1	Trastuzumab (Herceptin)FDA Link 02/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2006
1	epidermal growth factor receptor VIIIIBA 08/2003
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 06/2002

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2006
13	Radiotherapy 11/2023 - 11/2009
2	Drug Therapy (Chemotherapy) 01/2023 - 09/2015
2	Immunotherapy 01/2018 - 09/2015
1	Adjuvant Radiotherapy 01/2023
1	Craniotomy 01/2023
1	Aftercare (After-Treatment) 01/2019
1	Chemoradiotherapy 01/2018